Advertisement

Topics

Funding round brings in $1.4M for Bone Biologics

06:54 EDT 23 Aug 2017 | SmartBrief

A round of financing brought in $1.4 million for Bone Biologics, a Burlington, Mass.-based company that develops orthobiologi -More

Original Article: Funding round brings in $1.4M for Bone Biologics

NEXT ARTICLE

More From BioPortfolio on "Funding round brings in $1.4M for Bone Biologics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...